ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q1 2024 | $2 | +100.0% | 121 | 0.0% | 0.00% | – |
| Q4 2023 | $1 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q3 2023 | $1 | -50.0% | 121 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 121 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 121 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 121 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -33.3% | 121 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | +100.0% | 121 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 121 | +83.3% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | – | 66 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |